ALRX, LVLV, DUSS, SGCA, NFES, NVSR, HGSI, AMNE, ICOP, CSUN, BLKL OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, July 21st

ALRX, LVLV, DUSS, SGCA, NFES, NVSR, HGSI, AMNE, ICOP, CSUN, BLKL OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, July 21^st

 

Our Stocks to Watch today include AlphaRx Inc. (OTCBB: ALRX), LEVEL Vision Electronics Ltd. (OTC: LVLV), Dussault Apparel Inc. (OTCBB: DUSS), Strategic American Oil Corp. (OTCBB: SGCA), NF Energy Saving Corp. (OTCBB: NFES), NavStar Technologies Inc. (OTC: NVSR), Human Genome Sciences Inc. (Nasdaq: HGSI), American Green Group Inc. (OTC: AMNE), ICOP Digital Inc. (Nasdaq: ICOP), China Sunergy Company Ltd. (Nasdaq: CSUN) and Blink Logic Inc. (OTCBB: BLKL).

 

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.

 

ALPHARX INCORPORATED (OTCBB: ALRX)

"Up 5.36% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/ALRX.php

 

Company Profile: http://www.otcpicks.com/alpharx/alpharx.htm

 

AlphaRx is a specialty pharmaceutical company dedicated to developing proven therapies by reformulating FDA approved and marketed drugs which through the application of its proprietary site-specific nano drug delivery technology, offers improved medical benefits and a potential for significant commercial product development.

 

ALRX News:

 

July 21 - AlphaRx Unveils its China Strategy

 

AlphaRx (OTCBB: ALRX), an emerging biopharmaceutical company, utilizing proprietary drug delivery technology to develop novel formulations of drugs, is forging ahead with its growth strategy for Greater China. As part of this strategy, AlphaRx is poised to open a "state of the art" R D and pilot plant facility in China with local partners. The R D facility will focus on the development of innovative drug products targeting infectious disease and various forms of cancer. Additionally, the Company, together with its local partners, plans to develop adjuvant vaccines to treat influenza, such as H5N1 and H1N1 strains.

 

AlphaRx currently has a topical NSAID awaiting near-term registration in China and is developing a second product — GAI-122 — an injectable nanoemulsion, in collaboration with Gaia BioPharma for the treatment of acute hepatitis, a therapy with a multi-million dollar potential indication in China.

 

The Chinese government has been a strong supporter of the life sciences industry. It plans to further increase its investment in the sector through a variety of grants and awards in some of its leading science and technology parks and through the National Program 863, originally established in March 1983 by Deng Xiaoping to award grants to science and technology projects that have significant commercial value. Most notably, in November 2008, China launched the Mega New Drug Development Program, a plan to invest $10 billion over the next 13 years, with the aim of creating a China-based innovative drug development industry.

 

AlphaRx Inc. Rated a 'Speculative Buy' by Beacon Equity Research

 

AlphaRx Inc. (OTCBB: ALRX) has been rated a “Speculative Buy” by Beacon Analyst, Victor Sula, Ph.D.

 

The full report is available at www.beaconequity.com.

 

In the report, the analyst writes, “ALRX is using partnerships with pharmaceutical companies and research institutions to leverage its own financial and R&D resources, reduce risk, and minimize out-of-pocket expenditures. The Company enters into partnerships for specific products at the early stage of product development through research collaborations or in some cases, will advance the product to clinical trials before seeking a development and/or commercialization partner.

 

“Assuming successful commercialization, 10% market penetration and 5% royalties from product sales, ALRX could be generating a $30 million annual royalty income stream from GAI-122 alone. The sales opportunity associated with Zysolin™ is equally as impressive. Based on estimates of a $450 million U.S. market for inhaled Tobramycin, 8% market penetration and a marketing agreement with a large pharmaceutical company, revenues from Zysolin™ sales could easily exceed $40 million just from VAP applications.”

 

Other companies providing drug delivery systems: Novartis AG (NYSE: NVS), Gilead Sciences Inc. (Nasdaq: GILD), Nektar Therapeutics (Nasdaq: NKTR) and Paladin Labs Inc. (NYSE: PLB).

 

LEVEL VISION ELECTRONICS LTD. (OTC: LVLV)

 

Detailed Quote: http://www.otcpicks.com/quotes/LVLV.php 

 

Company Profile: http://www.otcpicks.com/level-vision-electronics/level-vision-electronics.htm

 

LEVEL Vision Electronics is an ODM/OEM (designer and manufacturer) of consumer electronics (mainly Wireless Handsets) primarily concentrating on the world's emerging markets. Through its Unique Business Model, LEVEL works hand-in-hand with the Telcos to customize the products to their specific targeted market requirements. Our current 3D products can be found online at www.levelelectronics.com and our upcoming related wireless handset software products are currently under development.

 

LVLV News:

 

July 21 - LEVEL Upgrading Its Website With Investor Aimed Information

 

LEVEL Vision Electronics Ltd. (OTC: LVLV) announced that it is currently putting final touches on its newly re-designed Website to keep Investors and the public informed of current Information, weekly News and New Product updates.

 

The new design is in line with LEVEL's plans to reach out to the public and inform shareholders and prospective investors on the company's roadmap. The following is a brief description of what will be available on the website; Stock quotes, Management & Board of Directors' resumes, current Product line, General and Specific Information about the company and much more. The official website address, as well as its "Go Live" date, will be released in an upcoming press release.

 

"With heavy requests for more information about the company coming in via our current website, we felt it timely to design a new and updated site which will allow the public to view and read all current information and public news. The Company information will now be available in one convenient place with a fresh new look," said Habib Coriaty, President and CEO of Level Vision Electronics Ltd. "In addition to the recent announcement of our new Corporate Finance Advisors, Hilbroy Advisory Inc., we are reaching out to the world's markets with information aimed at current shareholders and prospective investors," added Mr. Jean-Francois Lefebvre, Vice President of LEVEL Vision Electronics Ltd.

 

DUSSAULT APPAREL INCORPORATED (OTCBB: DUSS)

 

Detailed Quote: http://www.otcpicks.com/quotes/DUSS.php 

 

Company Profile: http://www.otcpicks.com/dussault-apparel.htm

 

Dussault Apparel, Inc. is a designer, manufacturer, wholesaler and retailer of high-end quality apparel, its expanding product line includes custom designed hoodies, jeans, jewelry, t-shirts, hats and leather goods. An accelerated growth company, Dussault Apparel, Inc. trades on the Nasdaq OTC bulletin board.

 

DUSS News:

 

July 20 - Dussault Apparel Inc. Signs Agreement With Canadian Distributor EHM Holdings

 

Dussault Apparel Inc. (OTCBB: DUSS) (the Company) announced that its moderately priced lifestyle brand Deuce by Dussault will be distributed in Canada by EHM Holdings based in Vancouver, BC, the company is one of the leading distributors in the territory representing brands such as DKNY, Mexx, True Religion Mynk and many more. EHM Holdings plans to introduce Deuce by Dussault to the Canadian market in the late summer, fall of 2009.

 

"As we continue to develop the Dussault brand, we are very pleased to be working with Ted Margulius and his team at EHM Holdings for distribution of the Deuce Collection. Canada's embrace of our brand has been significant for Dussault and I have big hopes for the success of our new collection," said Jason Dussault founder and CEO of Dussault Apparel Inc.

 

"We are very excited about our association with Dussault Apparel. The people are great and it's such a cool and unique brand, I think the public will embrace it," said Ted Margulius of EHM Holdings.

 

STRATEGIC AMERICAN OIL CORPORATION (OTCBB: SGCA)

 

Detailed Quote: http://www.otcpicks.com/quotes/SGCA.php 

 

Company Profile: http://www.otcpicks.com/strategic-american-oil/strategic-american-oil.htm

 

Strategic American Oil Corporation is an exploration and production company with operations in Texas, Oklahoma, Louisiana, and Illinois. The company draws on the experience of an internationally recognized team of geologists, engineers, and executives with extensive oil and gas exploration and production experience. The Company's objective is to find and acquire oil and gas projects of merit and develop those projects to their full potential.

 

SGCA News:

 

July 21 - Strategic American Oil Corporation Identifies Two Pinnacle Reef Targets in Illinois

 

Strategic American Oil Corporation (OTCBB: SGCA) (the "Company") announces that it has identified two Devonian-Silurian aged Pinnacle Reef (oil) prospects in the Illinois Basin through the research of records from the Illinois State Geological Survey. The prospects are located in Fayette and Macon Counties at depths of between 2000' and 3500' The Company plans to lease approximately 600 acres over the identified prospects and proposes to drill and/or generate 3D seismic to evaluate the prospective subsurface geology. The Company's exploration team believes the targets identified could contain significant oil reserves (detailed geologic information will be released upon completion of leasing).

 

Company President and CEO, Randall Reneau, stated, "The identification of these prospects furthers our exploration plans for Illinois. Our team in Illinois, lead by Chief Geologist Jim Thomas who has over 35 years experience working in the Illinois Basin, is continuing to make progress in finding and leasing new attractive targets, furthering our business model of developing prospects in-house to build the Company's oil reserves and increase production. The Company will continue to review and evaluate data from the Illinois State Geological Survey to identify new drilling prospects with the goal of making new oil field discoveries."

 

Pinnacle Reefs are isolated biohermal structures. These reefs are relatively shallow in Illinois, averaging between 2,000 to 3,500 feet in depth, allowing for low cost drilling programs. The Company's geologists have made extensive use of Illinois State historical coal drilling records; these records show coal seams overlaying pinnacle reefs that are marked as thinning and/or are structurally higher than expected making historic coal drilling logs extremely valuable in the search for pinnacle reefs. Due to the shallow depths of these structures, the Company will rely heavily on subsurface structural mapping to delineate possible reef targets. Targets below 3000' may be cost effective to utilize 3D seismic surveys prior to drilling. Each reef prospect will be evaluated as to the most cost effective exploration program as targets below 3000' may be cost effective to utilize 3D seismic surveys prior to drilling. According to the Illinois Geological Survey, successfully drilled and producing pinnacle reefs in the Basin produced an average of 3,200,000 barrels of oil. With today's advances in subsurface mapping and advanced 3D techniques, Pinnacle Reefs have become a prospective target for new oil field discoveries in the Illinois Basin.

 

NF ENERGY SAVING CORPORATION (OTCBB: NFES)

"Up 3.61% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/NFES.php 

 

Company Profile: http://www.otcpicks.com/nf-energy-saving-corp.htm

 

NF Energy Saving Corporation of America is a China-based provider of integrated energy conservation solutions utilizing energy-saving equipment, technical services and energy management re-engineering project operations to provide energy saving services to clients. Headquartered in Shenyang city of China, the Company currently has 220 employees and several proprietary energy saving technologies and patents.

 

NFES News:

 

July 21 - NF Energy Saving Corporation Announces $5.21 Million Order For Energy-Efficient Flow Control Systems

 

Proprietary Systems to Be Used at Yunnan Amojiang Power Plant Scheduled Delivery of $1.1 million of Energy-Efficient Flow Control Systems in Q3 2009

 

* Total contract value amounts to US$1.09 million in revenue to be recognized in Q3 2009

* Per US GAAP would be roughly US$0.93 million

 

NF Energy Saving Corporation (OTCBB: NFES) ("NF Energy"), a Chinese leader in energy efficient flow control systems, announced the $3.27 million of energy-efficient flow control systems for Yunnan Amojiang Hydro Power Plant, $1.09 million of which are to be delivered in Q3 2009.

 

Yunnan Amojiang Power Plant is a hydro power plant with design capacity of 99MW of generation capacity. Its total investment is RMB761 million (US$111.4 million).

 

"We are honored to participate in this important hydro project as it is an important component in China's move towards cleaner energy sources," commented Mr. Li Gang, Chairman and CEO of NF Energy. "We will continue to develop our energy-efficient flow control equipment in the hydro power market."

 

NAVSTAR TECHNOLOGIES INCORPORATED (OTC: NVSR)

"Up 57.78% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/NVSR.php

 

NavStar is focused on the creation of GPS products and services that provide wireless tracking of vehicles, equipment, and other valuable and personal assets. The goal is to be a total solutions provider.

 

NVSR News:

 

July 21 - NavStar Technologies, Inc. Narrows Search for Software Company Acquisition

 

NavStar Technologies, Inc. (OTC: NVSR), a multinational firm focused on developing and commercializing asset tracking and monitoring devices for vehicles and high value cargo with specific geographic focus in Latin America, announces that their efforts to acquire an annuity-based services/software company has been narrowed down to two companies.

 

N. Douglas Pritt, Chairman and CEO, confirmed that negotiations are underway with the final two candidates and that a Letter of Intent will be announced in the next two weeks.

 

NavStar also re-affirmed guidance regarding its expected financial performance over the next 5 years. The successful achievement of these financial objectives assumes the company's procurement of up to $2.0 million of funding in the 3rd quarter of this year and the completion of the services/software company. The summary financial income statement follows:

 

Based on the additional service revenue which will accrete to the base financial model, this acquisition should allow NavStar to galvanize additive revenue which will reoccur year to year based on the deployment of the asset tracking devices through customers in Latin America. Several Latin American customers/governments have already indicated under binding Letters of Intent a desire to acquire the company's products.

 

N. Douglas Pritt, Chairman and CEO, said, "In addition to the reoccurring monthly service revenue which we will realized from this acquisition, we will also be in a position to respond quickly to customers' request for quotes (RFQ) and offer customized solutions that competitors will have difficulty matching."

 

HUMAN GENOME SCIENCES INCORPORATED (NASDAQ: HGSI)

"Up 14.47% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/HGSI.php

 

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer. The Company's primary focus is rapid progress toward the commercialization of its two lead drugs, Albuferon® (albinterferon alfa-2b) for hepatitis C and BENLYSTA(TM) (belimumab, formerly LymphoStat-B®) for lupus. Albuferon has now completed Phase 3 development, and the filing of global marketing applications is expected in fall 2009. Two Phase 3 trials of BENLYSTA are ongoing, with results expected in July and November 2009. In April 2009, HGS completed delivery of 20,000 doses of raxibacumab (ABthrax(TM)) to the U.S. Strategic National Stockpile for use in an emergency for the treatment of inhalation anthrax. The Company also has several drugs in earlier stages of clinical development for the treatment of cancer, led by the TRAIL receptor antibody HGS-ETR1 and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.

 

HGSI News:

 

July 20 - Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA™ in Systemic Lupus Erythematosus

 

BENLYSTA (Belimumab) Met Its Primary Efficacy Endpoint by Achieving a Statistically Significant Improvement in Patient Response Rate Versus Placebo in BLISS-52; First Drug for Lupus to Reach This Advanced Stage of Clinical Development and Achieve Positive Results, in the Largest Randomized Placebo-Controlled Clinical Trial Ever Completed in SLE Patients

 

Human Genome Sciences, Inc. (Nasdaq: HGSI) and GlaxoSmithKline PLC (GSK) announced that BENLYSTA™ (belimumab, formerly LymphoStat-B) met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). In the placebo-controlled BLISS-52 study, the results showed that BENLYSTA plus standard of care achieved a clinically and statistically significant improvement in patient response rate at Week 52, compared with standard of care alone. Study results also showed that belimumab was generally well tolerated, with adverse event rates comparable between belimumab and placebo treatment groups.

 

"The BLISS-52 results demonstrated that BENLYSTA has the potential to become the first new approved drug in decades for people living with systemic lupus," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "Given the limited treatment options currently available, patients would benefit greatly from potential new treatments. BENLYSTA is an outstanding example of the type of treatment HGS is working to develop and bring to patients. Assuming positive results in November from our second Phase 3 trial of BENLYSTA, we and GSK plan to submit marketing applications in the United States, Europe and other regions in the first half of 2010."

 

Belimumab is an investigational drug and the first in a new class of drugs called BLyS-specific inhibitors. No new drug for lupus has been approved by regulatory authorities in more than 50 years. Belimumab is being developed by HGS and GSK under a co-development and commercialization agreement entered into in August 2006.

 

"Lupus is a chronic, often debilitating, and sometimes fatal illness that affects an estimated five million people worldwide and can have a devastating effect on both patients living with the disease and their families," said Carlo Russo, M.D., Senior Vice President, Biopharm Development, GSK. "BENLYSTA is the first medicine being developed specifically for lupus that has reached this late stage of clinical development with positive results. We look forward to completing the pivotal studies, with the hope of bringing this potentially important therapeutic advance to patients suffering from SLE."

 

AMERICAN GREEN GROUP INCORPORATED (OTC: AMNE)

"Up 27.12% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/AMNE.php 

 

AMNE is moving into the six billion building insulation business by becoming a cutting edge chemical sales company. The company is creating a new, wholly owned subsidiary to operate this business which will be headed by Terry Mixon, who plans on implementing this business strategy by using the web, mailing, telephone marketing, and television advertising campaign to grow our associate applicator membership to at least 5 distributor companies in each state. AMNE will begin by recruiting known successful application companies in each state then begin a web-based associate membership drive. The corporation will offer equipment, training and great pricing plus marketing support through the web program to all new associates.

 

AMNE News:

 

July 21 - AMNE Receives Approval From FINRA for 5-for-1 Forward Split

 

American Green Group, Inc. (OTC: AMNE) announced the Company has received approval from FINRA to proceed with its 5-1 Forward Stock Split.

 

The record date is July 31, 2009 and the Ex-Dividend Date is August 5, 2009 the shares will be delivered to shareholders without any further action on their part.

 

AMNE appreciates the patience of its shareholders while the Company went through this very lengthy process. The Company strives to deliver and perform for the shareholders, but cannot anticipate the kind of delays it recently dealt with in trying to get approval for the forward split.

 

In other News...

 

AMNE would like to invite everyone to visit its news web site www.americangreengroup.com and join the mailing list. The Company was successful in obtaining its original domain name and has been working to integrate all the components of the Company in one site.

 

Over the course of the next few weeks the Company will continue to update shareholders of the recent progress the Company has made in several areas.

 

ICOP DIGITAL INCORPORATED (NASDAQ: ICOP)

"Up 25.85% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/ICOP.php

 

ICOP Digital's products capture the true story. ICOP provides in car video solutions and mobile video solutions for use in the law enforcement, fire, EMS, public transit, and pupil transportation markets. With customers in 49 states in the U.S., ICOP solutions provide the highest quality video evidence through the use of state of the art digital imaging technology. The evidence captured is a critical component used by customers for the: conviction of criminals, enforcement of laws, reduction of crime, exoneration of personnel, and saving of litigation/settlement expenses.

 

ICOP News:

 

June 16 - ICOP Announces Exercise of Green Shoe Option by Paulson Investment Company, Inc.

 

ICOP Digital, Inc. (NASDAQ: ICOP), an industry-leading company engaged in advancing digital surveillance solutions, announced Paulson Investment Company, Inc., a wholly owned subsidiary of Paulson Capital Corp, (NASDAQ: PLCC) has opted to exercise the over-allotment option for 97,500 units on the most current ICOP offering, which closed June 5, 2009. Additional net proceeds to the Company are $403,650.

 

The Green Shoe grants Paulson, lead underwriter on the June 5, 2009 offering, a 45-day option to exercise the additional units. "We are very pleased to have been able to work with ICOP in raising these additional funds," said Chet Paulson, Founder and Chairman of Paulson Investment Company, Inc.

 

"The continued vote of confidence from Paulson is greatly appreciated," said Dave Owen, Chairman and Chief Executive Officer of ICOP Digital, Inc. "We believe the extra proceeds will help us continue to accelerate the execution of our business plan."

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

 

ABOUT PAULSON CAPITAL CORPORATION

 

Paulson Capital Corporation is the parent company to Paulson Investment Company, Inc. Headquartered in Portland, Oregon, Paulson Investment Company, Inc. is the Northwest's largest independent brokerage firm and a national leader in public offerings of small and emerging growth companies with capital needs of $5 million to $45 million. Founded by Chester "Chet" Paulson in 1970, it has managed or underwritten 164 securities offerings and has generated more than $1.2 billion for client companies. Paulson Investment Company, Inc. has 37 branch offices throughout the country.

 

CHINA SUNERGY COMPANY LIMITED (NASDAQ: CSUN)

"Up 12.49% in morning trading"

 

Detailed Quote: http://www.otcpicks.com/quotes/CSUN.php

 

China Sunergy Co., Ltd. is a specialized manufacturer of solar cell products in China. China Sunergy manufactures solar cells from silicon wafers utilizing crystalline silicon solar cell technology to convert sunlight directly into electricity through a process known as the photovoltaic effect. China Sunergy sells solar cell products to Chinese and overseas module manufacturers and system integrators, who assemble solar cells into solar modules and solar power systems for use in various markets.

 

CSUN News:

 

July 10 - China Sunergy to Hold Annual General Meeting on August 25, 2009

 

China Sunergy Co., Ltd. (Nasdaq: CSUN) ("China Sunergy" or the "Company"), a specialized solar cell manufacturer based in Nanjing, China, announced that it will hold its Annual General Meeting ("AGM") on August 25, 2009 at 9:00 a.m. (China Time). The AGM will be held at No. 123, West Focheng Road, Jiangning Economic & Technical Development Zone, Nanjing, Jiangsu, 211100, People's Republic of China.

 

Holders of record of ordinary shares of the Company at the close of business on June 30, 2009, are entitled to notice of, and to vote at, the AGM or any adjournment or postponement thereof. Holders of the Company's American depositary shares ("ADSs") who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company's ADS program, JPMorgan Chase Bank, N.A.

 

The AGM will discuss and seek adoption of the following resolutions to be proposed by the Company:

 

Proposal No. 1 - Re-election of Mr. Jianhua Zhao as a Class B director of the Company.

 

Proposal No. 2 - Re-election of Mr. Steve Morgan as a Class B director of the Company.

 

Proposal No. 3 - Re-election of Ms. Merry Tang as a Class B director of the Company.

 

Proposal No. 4 - Appointment of the Independent Auditor Deloitte Touche Tohmatsu CPA Ltd. for the fiscal year 2009.

 

Proposal No. 5 - The directors and each of Tingxiu Lu and Ruennsheng Allen Wang (each, an "Officer") be, and hereby are, authorized to take any and every action that might be necessary to effect the foregoing proposals 1 to 4 as such director or officer, in his or her absolute discretion, thinks fit.

 

BLINK LOGIC INCORPORATED (OTCBB: BLKL)

 

Detailed Quote: http://www.otcpicks.com/quotes/BLKL.php 

 

Blink Logic Inc. partners with ISVs to deliver SaaS Business Intelligence (BI) solutions to business executives in companies of all sizes. With the Blink Logic platform, ISVs can enhance their customer offerings to include powerful, yet easy-to-understand, reporting and analytics. Executives can leverage a full range of BI capabilities and actionable information to enable them to make better, faster, more informed decisions, in order to continuously increase revenue, customer satisfaction and profitability. Blink Logic is provided as a secure internet-based solution. By sharing the software, hardware, maintenance and support costs across tens of thousands of customers, Blink Logic delivers tremendous capability to its partners and their customers at a low monthly subscription price.

 

BLKL News:

 

July 20 - Blink Logic Participates in BeyeNETWORK's Software-as-a-Service Research Study

 

Research Study Focuses on the Benefits of Software as a Service (SaaS) and How Customers Are Using SaaS in a Decision-making Environment

 

Blink Logic Inc. (OTCBB: BLKL), the innovation leader in Software as a Service (SaaS) Business Intelligence (BI) announced its participation in the recent research study, Pay as You Go: Software as a Service Business Intelligence and Data Management. This study was published by BeyeResearch™, a community resource produced by the Business Intelligence Network.

 

The study, conducted by Claudia Imhoff of Intelligent Solutions and Colin White of BI Research, focuses on the benefits of software as a service (SaaS) and how this applies to business intelligence. With SaaS gaining more and more attention, there is still some confusion around SaaS and if a BI solution can thrive in a SaaS environment. The study also includes case studies highlighting real customer experiences and “lessons learned” when implementing a SaaS solution.

 

“In these tough economic times, it’s more important than ever for decision makers to have the information they need, when they need it and to immediately be able to slice and dice that data,” says David Morris, CEO of Blink Logic. “Companies can’t afford to spend the months it would take to install a system in house or the years it would take to build it themselves. SaaS BI is extremely cost effective and has a very low risk.”

 

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

 

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

 

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

 

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

 

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

 

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org.

 

Disclosure: OTCPicks.com has been compensated seven thousand five hundred dollars by a third party (Blue Wave Advisors) for ALRX advertising and promotional services. OTCPicks.com has been compensated three hundred thousand free trading shares from a third party (Cap Inc.) for LVLV advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars by a third party (BlueWave Advisors) for DUSS advertising and promotional services. Previously OTCPicks.com has been compensated two thousand dollars by a third party (Planning Media) for DUSS advertising and promotional services. OTCPicks has been compensated ten thousand shares from a non-controlling third Party (Pentony Enterprises) for SGCA advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars by a third party (Blue Wave Advisors) for NFES advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by the company for BLKL advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.